Friday, September 18, 2020 9:53:49 AM
Shorts're gonna be roasted and burnt.
$SBFM will make us wealthier.
Know What You Own
Sunshine BioPharma (SBFM) Surges on $2 Million Funding; Four Potential Inhibitors
https://microcapdaily.com/sunshine-biopharma-sbfm-surges-on-2-million-funding-four-potential-inhibitors/127822/
Sunshine Biopharma Secures $2,000,000 + Financing for Coronavirus Treatment
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158297344
Sunshine Biopharma Completes the Synthesis of Four Potential Inhibitors of Coronavirus Protease
https://www.accesswire.com/603154/Sunshine-Biopharma-Completes-the-Synthesis-of-Four-Potential-Inhibitors-of-Coronavirus-Protease
Share valuation:
As per MNP (one of the largest public accountancy firms in Canada), an estimated Fair Market Value of issued and outstanding shares of SBFM as at March 31, 2017 was in the range of $977.0 million to $1,133.0 million.
So, Estimated PPS of SBFM (in 2017) = $1,100 million/278 million = $3.95 (Without COVID-19 Patent)
Presently, PPS of most COVID-19 stocks are between $4 through $100.
We may see multiple bids, bidding wars and then finally hostile take over bids among Pharma giants. Wait and enjoy the ride.
Flippers are gonna rush to buy back SBFM shares over 30 Cents per share in coming days.
Folks! act prudently and be financially solvent at this very very difficult time.
https://finance.yahoo.com/news/sunshine-biopharma-releases-results-independent-130000009.html
Sunshine Biopharma Signs Licensing Agreement for Anastrozole, the Company’s First Generic Drug for Treatment of Breast Cancer
https://stockdaymedia.com/sunshine-biopharma-signs-licensing-agreement-for-anastrozole-the-companys-first-generic-drug-for-treatment-of-breast-cancer/
https://ca.finance.yahoo.com/news/sunshine-biopharma-files-patent-application-130000935.html
https://www.sunshinebiopharma.com/anticancer-drugs/#generic-drugs
Recent SBFM News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:05:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 03/05/2024 09:37:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:03:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:28:39 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/21/2024 01:24:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 04:39:32 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:53:03 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/14/2024 04:18:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/13/2024 05:15:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:05:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:04:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:17:56 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:17:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 05:38:24 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/08/2024 01:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:59:51 PM
- Sunshine Biopharma Moves Principal Office to New York City • GlobeNewswire Inc. • 12/04/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:00:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 04:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 05:06:33 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/19/2023 04:10:36 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM